Malnutrition is associated with poor survival in women receiving radiotherapy for cervical cancer

被引:4
|
作者
Laan, Janna [1 ,2 ]
van Lonkhuijzen, Luc [2 ,3 ]
Hinnen, Karel [1 ]
Pieters, Bradley [1 ,2 ]
Dekker, Inge [4 ]
Stalpers, Lukas [1 ,2 ]
Westerveld, Henrike [1 ,5 ]
机构
[1] Locat Univ Amsterdam, Dept Radiat Oncol, Amsterdam UMC, NL-1105 AZ Amsterdam, Netherlands
[2] Canc Ctr Amsterdam, Canc Treatment & Qual Life, Amsterdam, Netherlands
[3] Locat Univ Amsterdam, Dept Gynecol, Amsterdam UMC, Amsterdam, Netherlands
[4] Locat VUmc, Dept Nutr & Dietet, Amsterdam UMC, Amsterdam, Netherlands
[5] Erasmus MC, Dept Radiotherapy, Rotterdam, Netherlands
关键词
Uterine Cervical Neoplasms; Radiotherapy; Radiation Oncology; BODY-MASS INDEX; RISK-FACTORS; WEIGHT-LOSS; PREVALENCE; CARCINOMA; TOXICITY; OUTCOMES; ALCOHOL;
D O I
10.1136/ijgc-2023-005024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveCancer patients are at risk of malnutrition, which is associated with poor oncological outcomes. The aim of this study was to assess the incidence of malnutrition before, during, and after radiotherapy in locally advanced cervical cancer patients. In addition, we evaluated the impact of malnutrition on survival, and whether and when malnourished patients were referred to a dietitian.MethodsThis retrospective cohort study included cervical cancer patients who received primary or adjuvant radiotherapy with curative intent between January 2013 and January 2021. Patient and treatment characteristics, including longitudinal data on weight and dietary care, were retrieved from the electronic patient files. Malnutrition was defined by body mass index and weight loss according to the Global Leadership Initiative on Malnutrition (GLIM). Overall survival was estimated using the Kaplan-Meier method. Cox proportional hazard regression analysis was used to estimate hazard ratios for key prognostic factors.ResultsA total of 294 patients were included. Median follow-up was 40 months (range 7-101 months). Malnutrition occurred in 44 patients (15%) at baseline, in 132 (45%) during radiotherapy, and in 63 (21%) during follow-up. Referral to a dietician occurred in 45% of the 138 patients who were malnourished before or during radiotherapy. Malnutrition was significantly associated with worse survival after adjusting for age, performance score, diabetes, histology, International Federation of Gynecology and Obstetrics (FIGO) stage, and nodal stage. The 3 year overall survival in patients with malnutrition was 77% (95% confidence interval (CI) 70% to 85%) and without malnutrition 89% (95% CI 83% to 95%); p=0.001). Independent significant risk factors for worse overall survival were: malnutrition, age >52 years, adenocarcinoma, FIGO stage III/IV, and N1 disease.ConclusionMalnutrition was common in cervical cancer patients treated with radiotherapy and was associated with a shorter overall survival. Further studies are needed to evaluate the effectiveness of better monitoring of malnutrition and faster and better dietary intervention on survival and quality of life.
引用
收藏
页码:497 / 503
页数:7
相关论文
共 50 条
  • [21] Lower Urinary Tract Symptoms in Women with Cervical Cancer Receiving Radiotherapy with Curative Intent: A Prospective Observational Study
    Smit, S.
    Heyns, C.
    van der Merwe, A.
    Simonds, H.
    UROLOGY, 2012, 80 (03) : S143 - S144
  • [22] Radiotherapy: perception of women with uterine-cervical cancer
    Rios Barbosa de Almeida, Lucia Helena
    Araujo de Sousa Pereira, Yarla Brena
    de Oliveira, Thais Alexandre
    REVISTA BRASILEIRA DE ENFERMAGEM, 2008, 61 (04) : 482 - 487
  • [23] Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study
    Taguchi, Ayumi
    Furusawa, Akiko
    Ito, Kei
    Nakajima, Yujiro
    Shimizuguchi, Takuya
    Hara, Konan
    Takao, Maki
    Kashiyama, Tomoko
    Kino, Nao
    Karasawa, Katsuyuki
    Yasugi, Toshiharu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 955 - 962
  • [24] Tumor endothelium-derived PODXL correlates with immunosuppressive microenvironment and poor prognosis in cervical cancer patients receiving radiotherapy or chemoradiotherapy
    Huang, Rui
    Wang, Fuhao
    Zou, Wenxue
    Li, Xiaohui
    Lei, Tianyu
    Li, Peihang
    Song, Yajun
    Liu, Chao
    Yue, Jinbo
    BIOMARKER RESEARCH, 2024, 12 (01)
  • [25] Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study
    Ayumi Taguchi
    Akiko Furusawa
    Kei Ito
    Yujiro Nakajima
    Takuya Shimizuguchi
    Konan Hara
    Maki Takao
    Tomoko Kashiyama
    Nao Kino
    Katsuyuki Karasawa
    Toshiharu Yasugi
    International Journal of Clinical Oncology, 2020, 25 : 955 - 962
  • [26] The effect of addition of chemotherapy to radiotherapy in the treatment of women with cervical cancer: A survival analysis using propensity score
    Carmo, Claudio C.
    Luiz, Ronir R.
    Silva, Gustavo
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 271 - 275
  • [27] Association between travel distance and survival among women with locally advanced cervical cancer treated with radiotherapy
    Wang, Victoria
    Huang, YongMei
    Melamed, Alexander
    Schorge, John
    Wright, Jason
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S94 - S95
  • [28] Overexpression of miRNA 4451 is Associated With a Poor Survival of Patients With Hypopharyngeal Cancer After Surgery With Postoperative Radiotherapy
    Xu, Xinbo
    Liu, Heng
    Gross, Neil
    Wei, Dongmin
    Qian, Ye
    Li, Wenming
    Wei, Peng
    Li, Guojun
    Zhang, Fenghua
    Yang, Zheng
    Lei, Dapeng
    Pan, Xinliang
    TRANSLATIONAL ONCOLOGY, 2018, 11 (05): : 1244 - 1250
  • [29] Optimisation of radiotherapy and multimodality therapy for cervical cancer patients with poor prognosis
    Kasenka, I
    RADIOTHERAPY AND ONCOLOGY, 2003, 68 : S116 - S116
  • [30] Identification of Biomarkers for Cervical Cancer Radiotherapy Sensitivity and Survival Prognosis
    Huang, Han
    Ma, Jianguang
    Cui, Hekai
    Liang, Tiantian
    Ma, Qingqing
    ONCOLOGY RESEARCH AND TREATMENT, 2025,